Previous Article | Next Article ![]()
Infection and Immunity, June 1999, p. 2969-2974, Vol. 67, No. 6
Center of Gastrointestinal Biology and
Disease, University of North Carolina, Chapel Hill, North Carolina
27599,1 and Department of Infectious
Diseases, VA Medical Center, Duke University, Durham, North Carolina
277052
Received 29 October 1998/Returned for modification 15 February
1999/Accepted 16 March 1999
Resident bacteria play an important role in initiating and
perpetuating gastrointestinal inflammation. We previously demonstrated that six commensal bacteria including Bacteroides vulgatus
caused more aggressive colitis and gastritis in HLA-B27 transgenic rats than did the other five bacteria without B. vulgatus. This
study compared the degree of gastrointestinal inflammation in
gnotobiotic HLA-B27 transgenic rats monoassociated with either B. vulgatus or Escherichia coli. Gnotobiotic transgenic
rats raised in Trexler isolators were selectively colonized with either
B. vulgatus or E. coli. Control rats were
either germfree or colonized with six common commensal bacteria
(Streptococcus faecium, E. coli,
Streptococcus avium, Eubacterium contortum,
Peptostreptococcus productus, and B. vulgatus
[DESEP-B]). After 1 month, all the rats were killed and tissues were
prepared for histologic and biochemical evaluation. Colitis induced by
B. vulgatus monoassociation was almost equal to that in
DESEP-B-colonized rats and was significantly more severe than E. coli-induced colitis, which was absent by histological testing
and mild by colonic myeloperoxidase and interleukin-1 Extensive recent data support the
major influence of normal resident bacteria on the initiation and
perpetuation of intestinal inflammation and extraintestinal
manifestations in experimental colitis and human inflammatory bowel
disease (25-27). Luminal bacteria have been implicated in
the pathogenesis of multiple experimental colitis models (1, 3,
7-9, 20-22, 28, 32, 36). However, not all bacteria have equal
abilities to cause inflammation, as demonstrated by their differential
responses to antibiotics with narrow specificities and colonization
with defined bacterial subsets. Metronidazole, which is selectively
active against anaerobic bacteria, is effective in Crohn's colitis and
ileocolitis (31) and also attenuates chronic experimental
intestinal inflammation in the indomethacin- and carrageenan-induced
models (19, 36) and in HLA-B27 transgenic rats (23,
24). Anaerobic bacterial overgrowth in bypassed jejunoileal
segments created to treat morbid obesity leads to systemic inflammation
(6), and experimental small intestinal anaerobic bacterial
overgrowth through creation of a jejunal self-filling blind loop can
induce hepatobiliary inflammation and reactivate quiescent arthritis in
genetically susceptible Lewis rats (15, 16). Similarly,
experimental cecal anaerobic bacterial overgrowth potentates colitis in
HLA-B27 transgenic rats (23). In both human and rat small
intestinal bacterial overgrowth models, broad-spectrum antibiotics or
metronidazole can treat systemic manifestations (10, 14,
23). These results from experiments with multiple clinical and
experimental conditions suggest a dominant proinflammatory role for
anaerobic commensal bacteria.
Several resident bacteria have been associated with Crohn's disease,
ulcerative colitis, and chronic inflammation in animal models (26,
27). Luminal concentrations of Bacteroides
(13), Eubacterium, Peptostreptococcus,
and Coprococcus (33) are increased in Crohn's
patients, while facultative anaerobic bacteria such as
Streptococcus faecium (enterococcus, group D streptococcus) are increased in patients with ulcerative colitis (26).
Serum antibodies to Eubacterium,
Peptostreptococcus, and Coprococcus are
specifically increased in Crohn's disease (2), and
functionally altered Escherichia coli has been implicated in
the pathogenesis of ulcerative colitis (26). Furthermore,
luminal concentrations of E. coli and
Enterococcus species correlate with aggressiveness of
colitis in B27 transgenic rats (21). Bacteroides
vulgatus plays an essential role in the pathogenesis of
carrageenan-induced colitis in the guinea pig (20), and
purified cell wall polymers from Eubacterium,
Peptostreptococcus, and Streptococcus faecium can
induce or reactivate quiescent arthritis in genetically susceptible hosts (29, 30). Furthermore, gnotobiotic B27 transgenic rats colonized with a mixture of six different obligate and facultative anaerobic bacteria containing Streptococcus faecium (group
D), Streptococcus avium, Peptostreptococcus
productus, E. coli, Eubacterium contortum,
and B. vulgatus (DESEP-B) developed much more active colitis
and gastritis than did littermates colonized with the same mixture
without B. vulgatus (22).
These results suggest that B. vulgatus preferentially
induces colitis in B27 transgenic rats, but they do not conclusively exclude an adjunctive or even necessary confunctional role for the
other five bacterial strains cocolonizing these gnotobiotic rats. The
aims of the present study are to compare the abilities of two different
common commensal enteric bacteria, B. vulgatus and E. coli, to induce colitis and gastritis in monoassociated HLA-B27 transgenic rats and to compare the inflammatory effects of
these single bacterial strains with those of the cocktail of six
bacteria previously investigated in this model (22).
Experimental design.
HLA-B27/ Histological testing.
Tissues were fixed in 10% neutral
buffered formaldehyde for 4 to 12 h, transferred into 70%
ethanol, and processed the next day by standard techniques
(22). Coded samples were examined under light microscopy by
a single observer (H. C. Rath). Cecal and gastric inflammation
were quantitated by a previously validated histological scoring system
ranging from 0 to 4+ (22).
MPO assay.
Methods of tissue preparations and the assay of
colonic myeloperoxidase (MPO) activity (units per gram of tissue) were
described previously (11).
Enzyme-linked immunosorbent assay.
Interleukin-1 Microbial analysis.
Immediately after euthanasia, 1-ml
samples from the cecal contents of colonized nontransgenic rats were
taken and serially diluted in phosphate-buffered saline. Total
bacterial concentrations were determined by using counting chambers.
Monoassociation was confirmed by Gram staining and anaerobic culture.
Statistical analysis.
All data are expressed as mean ± standard error of the mean SEM. To test for differences between the
groups, analysis of variance was used. Samples with equal distribution
were compared by Student's t test. P < 0.05 was considered statistically significant.
Cecal inflammation.
There was no evidence of grossly
detectable inflammation in any group. Histologically, cecal
inflammation of DESEP-B-colonized rats was characterized as mononuclear
cell infiltration limited to the lamina propria with hypertrophy of the
mucosa, crypt dilatation, and focal crypt abscesses. Rats
monoassociated with B. vulgatus had a similar histologic
pattern (Fig. 1B) and by blinded
microscopic score had almost as much cecal inflammation as did the
positive controls colonized with the six commensals, including B. vulgatus (1.7 ± 0.2 and 2.1 ± 0.1, respectively
[P = 0.06]) (Fig. 2).
Rats monoassociated with E. coli had almost no cecal
inflammation (Fig. 1A), and their histologic scores were nearly
identical to those of GF animals (0.8 ± 0.2 and 0.7 ± 0.1, respectively [not significant]) (Fig. 2). Transgenic rats
monoassociated with B. vulgatus had more severe cecal
inflammation than did those monoassociated with E. coli
(P = 0.001). Cecal MPO activity confirmed the lack of difference between DESEP-B- and B. vulgatus-colonized rats
and the significantly increased inflammation in both of these groups compared with that in E. coli-monoassociated (P < 0.03) and GF (P < 0.0001) rats (Fig.
3). However, in contrast to the lack of histologic inflammation in E. coli-monoassociated rats,
colonic MPO levels were significantly increased in the E. coli group compared with GF controls (6.5 ± 1.0 and 1.1 ± 0.8, respectively [P < 0.0001]). IL-1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Differential Induction of Colitis and Gastritis in HLA-B27
Transgenic Rats Selectively Colonized with Bacteroides
vulgatus or Escherichia coli

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
concentration
determinations. However, gastritis was detectable only in
DESEP-B-associated rats. These studies suggest that not all resident
bacteria have equal proinflammatory capabilities, since B. vulgatus alone is more active than E. coli alone in
inducing colitis, and that colitis and gastritis result from different luminal bacterial stimuli.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
2-microglobulin
(HLA-B27) transgenic rats of the 33-3 line on an inbred
F344 background (12) raised under germfree (GF)
(sterile) conditions (22) were divided into four groups at
the age of 2 months. One group remained GF (n = 10) and
served as negative controls. The other groups were transferred into
separate isolators and then colonized with different bacteria or
bacterial cocktails by techniques described previously (22).
One group (n = 11) was selectively colonized with
B. vulgatus derived from a guinea pig with
carrageenan-induced colitis (a gift from A. B. Onderdonk, Harvard
University, Cambridge, Mass.). The second group (n = 8)
was monoassociated with E. coli derived from a patient with
active Crohn's disease and provided by the Clinical Microbiology Laboratory of the University of North Carolina Hospitals, Chapel Hill,
N.C. The third group (n = 12) was colonized with a
cocktail of six bacteria (DESEP-B) with previously reported
proinflammatory activity in this model (22) and served as a
positive control. These bacteria were isolated from patients with
Crohn's disease (except for B. vulgatus) and included the
B. vulgatus and E. coli strains used for
monoassociation of littermates. Persistent selective bacterial
colonization was documented by fecal Gram stain and culture 1 week
after colonization and at necropsy. All the rats were clinically
observed for evidence of diarrhea and arthritis and were killed at 3 months of age (1 month after colonization) by CO2
asphyxiation within 3 h of removal from the gnotobiotic isolators.
The cecal tip and antrum of each rat were fixed in 10% neutral
buffered formaldehyde for histological processing. Right colonic
segments were taken and snap frozen in methyl-butane at
80°C for
biochemical evaluations.
(IL-1
) protein concentrations in the cecal tissue were measured by a
rat IL-1
enzyme-linked immunosorbent assay developed by S. Poole
(National Laboratory of Biological Standards and Controls, South Mimms,
Potters Bar, Hertfordshire, United Kingdom) (22).
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
protein
concentrations in the cecal tissue were not significantly different
among the gnotobiotic groups; the concentrations in all groups were
significantly elevated compared to those in GF rats (DESEP-B rats,
34.8 ± 4.3 ng/g of tissue; B. vulgatus rats, 37.6 ± 3.3 ng/g; E. coli rats, 25.3 ± 4.6 ng/g
[P < 0.0005 with respect to GF rats, which had
5.2 ± 0.6 ng/g]; B. vulgatus versus E. coli was not significant [P = 0.06]). Total
luminal bacterial concentrations in the cecum were not different among
the groups (1.0 × 104 to 4.4 × 1011
bacteria/ml of cecal contents).

View larger version (140K):
[in a new window]
FIG. 1.
Histological features of colons from gnotobiotic
HLA-B27/
2-microglobulin transgenic rats monoassociated
with B. vulgatus or E. coli for 1 month. (A)
Cecal histological section from a transgenic rat monoassociated with
E. coli. There is almost no sign of inflammation. (B) Cecal
tissue from a transgenic rat monoassociated with B. vulgatus. There is mononuclear cell infiltration of the lamina
propria, mucosal thickening, crypt hyperplasia, and focal goblet cell
depletion. Magnification, ×40.

View larger version (24K):
[in a new window]
FIG. 2.
Blinded histological inflammatory scores of the cecum
and antrum in gnotobiotic HLA-B27 transgenic rats. GF transgenic rats,
2 months old, were colonized with DESEP-B, B. vulgatus
alone, or E. coli alone or kept GF (negative control). The
rats were killed 1 month after bacterial colonization. *,
P = 0.001 with respect to E. coli and GF
rats. §, P < 0.05 with respect to all three other
groups.

View larger version (31K):
[in a new window]
FIG. 3.
As a marker of neutrophilic infiltration, colonic MPO
activity was increased in all colonized rats with respect to GF
controls. Homogenized cecal tissues collected 1 month after bacterial
colonization were assayed by a colorimetric biochemical assay for MPO
(see Materials and Methods). *, P < 0.03 with
respect to E. coli and P < 0.0001 with
respect to GF rats. §, P < 0.0001 with respect to GF
rats and P < 0.01 with respect to DESEP-B.
Gastritis. Mononuclear inflammation in the gastric antrum is a prominent feature in specific-pathogen-free HLA-B27 transgenic rats, although it is absent in GF rats (22). As previously described, transgenic rats colonized with DESEP-B had active antral mucosal inflammation (histological scores of 1.4 ± 0.2 with respect to 0.6 ± 0.1 for GF rats [P < 0.05]) (Fig. 2). However, transgenic rats monoassociated with either B. vulgatus or E. coli had significantly less gastritis (0.8 ± 0.2 and 0.7 ± 0.2, respectively [P < 0.04] with respect to DESEP-B) and were not different from GF rats.
| |
DISCUSSION |
|---|
|
|
|---|
In a recent study we demonstrated that six common intestinal
commensals isolated from patients or guinea pigs with colitis, including B. vulgatus, could cause colitis and gastritis in
HLA-B27 transgenic rats (22). However, the same cocktail
minus B. vulgatus caused virtually no intestinal
inflammation. These data strongly incriminated B. vulgatus
in the pathogenesis of colitis and gastritis in HLA-B27 transgenic
rats. However, the question still remained whether this inflammation
was an effect of B. vulgatus alone or whether the other
bacteria in this cocktail had a synergistic or maybe even an
antagonistic influence. To address this question, we monoassociated GF
transgenic rats with either B. vulgatus or E. coli, another component of this cocktail. In the present study, we
demonstrated that B27 transgenic rats monoassociated with B. vulgatus developed colitis comparable to that in rats colonized with the six commensal bacteria but that E. coli-monoassociated rats had no histological evidence of colitis
although slight increases in MPO and IL-1
concentrations in tissue
were noted. Differential abilities to induce colitis were not due to
colonization efficiency, since colonic luminal concentrations of
B. vulgatus and E. coli were almost identical.
These observations are consistent with a series of results from our
group as well as from other investigators. Onderdonk et al.
demonstrated in complex repopulation and monoassociation studies that
B. vulgatus was the dominant stimulus in carrageenan-induced colitis in guinea pigs (20), and Dianda et al. showed that
T-cell receptor alpha (TCR
)-deficient mice monoassociated with
E. coli or Streptococcus faecium had no colitis
(9). Moreover, the therapeutic efficacy of metronidazole in
Crohn's disease correlates well with the degree of suppression of
fecal Bacteroides concentrations (13). Lichtman
et al. showed that chronic metronidazole therapy, which eliminated
Bacteroides spp. without significantly altering total
luminal bacterial concentrations, prevented hepatobiliary inflammation
and reactivation of arthritis in rats with jejunal self-filling blind
loops (14, 16). We recently reported that creation of a
cecal self-filling blind loop in B27 transgenic rats was associated
with 50-fold increased luminal concentrations of Bacteroides
species and potentiation of cecal inflammation (23).
Metronidazole eliminated luminal Bacteroides and attenuated colitis in this model (23). Furthermore, enterotoxin from
certain B. fragilis strains enhances mucosal permeability
and epithelial internalization of enteric bacteria (35), and
Bacteroides strains stimulate transforming growth factor
1 production and collagen deposition in the colonic wall in
decontaminated rats following 2,4,6-trinitrobenzenesulfonic acid
(TNBS)-ethanol (18). Finally, Cong et al. (7)
documented T-lymphocyte responses to B. vulgatus in
C3H/HeJBir mice with colitis. The lack of a significant
difference between the cecal inflammation of rats monoassociated with
B. vulgatus and those colonized with DESEP-B indicates that
none of the other five bacterial species exert a protective influence, especially since there was a strong trend towards more inflammation in
the commensal-colonized group. However, the fact that rats raised in a
specific-pathogen-free environment have more severe cecal inflammation
than those colonized with the cocktail of six defined commensal
bacteria (22) suggests that B. vulgatus is not
the only resident enteric bacterial strain capable of inducing and/or
perpetuating colitis in this model. It is possible that other strains
not represented in our cocktail can initiate disease or, alternatively,
that B. vulgatus selectively initiates colitis in this model
but that once it is initiated, other bacteria may play a role in
perpetuating and potentiating chronic intestinal inflammation. The
concept of synergistic activities of various resident luminal bacteria
in chronic intestinal inflammation is supported by our preliminary
observations that the broad-spectrum antibiotic combination of
vancomycin and imipenem is superior to metronidazole or ciprofloxacin
alone in preventing and treating experimental colitis in HLA-B27
transgenic rats (24). The complex interaction of various
luminal bacterial species is further illustrated by the recent
correlation of cecal concentrations of E. coli and to a
lesser extent Enterococcus species with the degree of
colitis in B27 transgenic rats (21). Although the
concentrations of anaerobes, including Bacteroides species,
were not increased in rats with severe colitis in the study by
Onderdonk et al. (21), Bacteroides was one of the
most prevalent organisms (109 CFU/g of cecal contents).
Neither of the two groups of monoassociated rats showed any significant
gastritis, whereas transgenic rats colonized with DESEP-B manifested
chronic antral inflammation. In our previous study of transgenic rats
colonized with these commensals excluding B. vulgatus, there
was no significant colitis or gastritis (22). In another
experiment, HLA-B27 transgenic rats in a specific-pathogen-free environment did not develop colitis or gastritis if the cecum was
excluded from the fecal stream, which caused a consequent decrease of
cecal bacterial concentrations of about 2 log units (23),
even though the bacterial concentration and composition in the gastric
lumen did not change. These results correspond to attenuation of distal
colitis in TCR
-deficient mice following excision of the cecal tip
("appendectomy") (17). We hypothesize that the
concentration and composition of cecal bacteria are important not only
in inducing local colitis but also in stimulating remote inflammation,
including the stomach. Cecal luminal bacteria prime lymphocytes in the
extensive lymphoid aggregates of the cecal tip, and then these
lymphocytes circulate systemically and home to remote mucosal organs,
where they are activated if they are exposed to the same bacterial
antigens present in the cecum. This hypothesis would explain (i) the
lack of gastritis in rats monoassociated with B. vulgatus,
since this obligate anaerobe is not present in high concentrations in
the partially aerobic stomach; (ii) the lack of gastritis in rats
monoassociated with E. coli, since E. coli does
not initiate aggressive chronic inflammation in the cecum; and (iii)
the presence of gastritis in DESEP-B-colonized rats, since B. vulgatus initiates the cecal inflammation, which enhances the
uptake of bacterial antigens from facultative anaerobes present in the
cecum as well as in the stomach. This hypothesis is supported by the
observation of Aranda et al. that SCID mice raised in a
specific-pathogen-free environment develop colitis and gastritis after
transfer of CD45RBhigh cells but that "reduced-flora"
SCID mice populated with three nonpathogenic Clostridium
spp. fail to develop colitis after cell transfer (1). It
also explains the observations that HLA-B27 transgenic nude rats raised
in a specific-pathogen-free environment develop colitis and gastritis
after transfer of lymphocytes from transgenic euthymic rats with
colitis (5) whereas GF transgenic rats do not develop
intestinal inflammation after receiving the same T cells
(24a). Although the failure to transfer colitis to euthymic
GF B27 transgenic recipients could be due to resistance of euthymic
recipients to colitis mediated by transferred lymphocytes (4), we have shown in preliminary studies that mesenteric
lymph node cells from specific-pathogen-free
CD3
26 transgenic mice with colitis also do
not transfer disease to GF athymic recipients (34).
These results indicate that (i) resident luminal bacteria are important in the initiation and perpetuation of chronic colitis and gastritis in HLA-B27 transgenic rats, (ii) not all bacterial strains have equal ability to cause gastrointestinal inflammation (some bacteria are more aggressive than others), and (iii) different bacteria play different roles in the inflammatory process (B. vulgatus plays a key role in initiating colitis in B27 transgenic rats, while other bacterial strains, although they cannot initiate colitis, play an important role in mediating inflammation in remote organs such as the stomach). These observations have important therapeutic implications for designing clinical trials investigating antibiotics with selective activity in Crohn's disease and ulcerative colitis.
| |
ACKNOWLEDGMENTS |
|---|
We gratefully thank Lisa Holt, Toni Grenther, and Julie Vorobiov for expert technical support and Susie May and Beverly Vought for secretarial assistance.
Grant support was provided by USPHS grants DK40249 and DK34989 and Deutsche Forschungsgemeinschaft (DFG) grant Ra 671/1-1 to H. C. Rath.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Division of Digestive Diseases, CB 7080, Room 030, Glaxo Bldg., University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7080. Phone: (919) 966-0149. Fax: (919) 966-7468. E-mail: rbs{at}med.unc.edu.
Present address: Klinik und Poliklinik für Innere Medizin I,
Universität Regensburg, Regensburg, Germany.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aranda, R., B. C. Sydora, P. L. McAllister, S. W. Binder, H. Y. Yang, S. R. Targan, and M. Kronenberg. 1997. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J. Immunol. 158:3464-3473[Abstract]. |
| 2. | Auer, I. O., A. Roder, F. Wensinck, J. P. van de Merwe, and H. Schmidt. 1983. Selected bacterial antibodies in Crohn's disease and ulcerative colitis. Scand. J. Gastroenterol. 18:217-223[Medline]. |
| 3. | Brandwein, S. L., R. P. McCabe, Y. Cong, K. B. Waites, B. U. Ridwan, P. A. Dean, E. H. Birkenmeier, J. P. Sundberg, and C. O. Elson. 1997. Spontaneously colitic C3H/HeJ Bir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol. 159:44-52[Abstract]. |
| 4. |
Breban, M.,
R. E. Hammer,
J. A. Richardson, and J. D. Taurog.
1993.
Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.
J. Exp. Med.
178:1607-1616 |
| 5. | Breban, M., J. L. Fernandez-Sueiro, J. A. Richardson, R. R. Hadavand, S. D. Maika, R. E. Hammer, and J. D. Taurog. 1996. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of the HLA-B27 transgenic rats. J. Immunol. 156:794-803[Abstract]. |
| 6. | Brown, R. G., J. P. O'Leary, and E. R. Woodward. 1974. Hepatic effects of jejunoileal bypass for morbid obesity. Am. J. Surg. 127:53-58[Medline]. |
| 7. |
Cong, Y.,
S. L. Brandwein,
R. P. McCabe,
A. Lazenby,
E. H. Birkenmeier,
J. P. Sundberg, and C. O. Elson.
1998.
CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease.
J. Exp. Med.
187:855-864 |
| 8. |
Contractor, N. V.,
H. Bassiri,
T. Reya,
A. Y. Park,
D. C. Baumgart,
M. A. Wasik,
S. G. Emerson, and S. R. Carding.
1998.
Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice.
J. Immunol.
160:385-394 |
| 9. | Dianda, L., A. M. Hanby, N. A. Wright, A. Sebesteny, A. C. Hayday, and M. J. Owen. 1997. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150:91-97[Abstract]. |
| 10. |
Drenick, E. J.,
J. Fisler, and D. Johnson.
1982.
Hepatic steatosis after intestinal bypass prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition.
Gastroenterology
82:535-548[Medline].
|
| 11. | Grisham, M. B., J. N. Benoit, and D. N. Granger. 1990. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol. 186:729-742[Medline]. |
| 12. | Hammer, R. E., S. D. Maika, J. A. Richardson, J. P/ Tang, and J. D. Taurog. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63:1099-1112. |
| 13. |
Krook, A.,
B. Lindstrom,
J. Kjellander,
G. Jarnerot, and L. Bodin.
1981.
Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
J. Clin. Pathol.
34:645-650 |
| 14. | Lichtman, S. N., J. Keku, J. H. Schwab, and R. B. Sartor. 1991. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100:513-519[Medline]. |
| 15. | Lichtman, S. N., R. B. Sartor, J. Keku, and J. H. Schwab. 1990. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 98:414-423[Medline]. |
| 16. | Lichtman, S. N., J. Wang, R. B. Sartor, C. Zhang, D. E. Bender, F. G. Dalldorf, and J. H. Schwab. 1995. Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, luminal bacteria and bacterial polymers. Infect. Immun. 63:2295-2301[Abstract]. |
| 17. |
Mizoguchi, A.,
E. Mizoguchi,
C. Chiba, and A. K. Bhan.
1996.
Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice.
J. Exp. Med.
184:707-715 |
| 18. | Mourelle, M., A. Salas, F. Guarner, E. Crespo, A. Garcia-Lafuente, and J. R. Malagelada. 1998. Stimulation of transforming growth factor beta 1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology 114:519-526[Medline]. |
| 19. |
Onderdonk, A. B., and J. G. Bartlett.
1979.
Bacteriological studies of experimental ulcerative colitis.
Am. J. Clin. Nutr.
32:258-265 |
| 20. |
Onderdonk, A. B.,
M. L. Franklin, and R. L. Cisneros.
1981.
Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora.
Infect. Immun.
32:225-231 |
| 21. |
Onderdonk, A. B.,
J. A. Richardson,
R. E. Hammer, and J. D. Taurog.
1998.
A correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease.
Infect. Immun.
66:6022-6023 |
| 22. | Rath, H. C., H. H. Herfarth, J. S. Ikeda, W. B. Grenther, T. E. Hamm, Jr., E. Balish, J. D. Taurog, R. E. Hammer, K. H. Wilson, and R. B. Sartor. 1996. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J. Clin. Investig. 98:945-953[Medline]. |
| 23. | Rath, H. C., J. S. Ikeda, H.-J. Linde, J. Schölmerich, K. H. Wilson, and R. B. Sartor. 1999. Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology 116:310-319[Medline]. |
| 24. | Rath, H. C., M. Schultz, L. A. Dieleman, F. Li, H. Kölbl, W. Falk, J. Schölmerich, and R. B. Sartor. 1998. Selective vs. broad spectrum antibiotics in the prevention and treatment of experimental colitis in two rodent models. Gastroenterology 114:A1067. (Abstract.) |
| 24a. | Rath, H. C., and R. B. Sartor. Unpublished results. |
| 25. | Sartor, R. B. 1997. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res. Immunol. 148:567-576[Medline]. |
| 26. | Sartor, R. B. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In J. B. Kirsner (ed.). Inflammatory bowel disease, in press. The Williams & Wilkins Co., Baltimore, Md. |
| 27. | Sartor, R. B., H. C. Rath, and R. K. Sellon. 1996. Microbial factors in chronic intestinal inflammation. Curr. Opin. Gastroenterol. 12:327-333. |
| 28. |
Sellon, R. K.,
S. L. Tonkonogy,
M. Schultz,
W. B. Grenter,
E. Balish,
D. M. Rennick, and R. B. Sartor.
1998.
Normal enteric flora are necessary for the development of spontaneous colitis and immune system activation in IL-10-deficient mice.
Infect. Immun.
66:5224-5231 |
| 29. | Severijnen, A. J., R. van Kleef, M. P. Hazenberg, and J. P. van de Merwe. 1989. Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats. J. Rheumatol. 16:1061-1068[Medline]. |
| 30. |
Stimpson, S. A.,
R. R. Brown,
S. K. Anderle,
D. G. Klapper,
R. L. Clark,
W. J. Cromartie, and J. H. Schwab.
1986.
Arthropathic properties of cell wall polymers from normal flora bacteria.
Infect. Immun.
51:240-249 |
| 31. |
Sutherland, L.,
J. Singleton,
J. Sessions,
S. Hanauer,
E. Krawitt,
G. Rankin,
R. Summers,
H. Mekhjian,
N. Greenberger,
M. Kelly,
J. Levine,
A. Thomson,
E. Alpert, and E. Prokipchuk.
1991.
Double blind, placebo controlled trial of metronidazole in Crohn's disease.
Gut
32:1071-1075 |
| 32. |
Taurog, J. D.,
J. A. Richardson,
J. T. Croft,
W. A. Simmons,
M. Zhou,
J. L. Fernandez-Sueiro,
E. Balish, and R. E. Hammer.
1994.
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.
J. Exp. Med.
180:2359-2364 |
| 33. | van de Merwe, J. P., A. M. Schroder, F. Wensinck, and M. P. Hazenberg. 1988. The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives. Scand. J. Gastroenterol. 23:1125-1131[Medline]. |
| 34. | Veltkamp, C., S. L. Tonkonogy, Y. P. de Yong, L. A. Dieleman, E. Balish, C. Terhorst, and R. B. Sartor. 1999. Continuous luminal stimulation is essential for colitis in TGE26 mice after bone marrow transplantation or T cell transfer. Gastroenterology 116:A838. (Abstract.) |
| 35. | Wells, C. L., E. M. van de Westerlo, R. P. Jechorek, B. A. Feltis, T. D. Wilkins, and S. L. Erlandsen. 1996. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology 110:1429-1437[Medline]. |
| 36. | Yamada, T., E. Deitch, R. D. Specian, M. A. Perry, R. B. Sartor, and M. B. Grisham. 1993. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17:641-662[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|